SCHEMBL25490042

SCHEMBL25490042

Cc1ccc(NC2CCC(N)C2)nc1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 5/20 0.44
▸ CYP11B1 P15538 1/20 0.44
▸ CYP11B2 P19099 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HCAR3 P49019 3/20 0.43
▸ CCR6 P51684 1/20 0.43
▸ PDE10A Q9Y233 2/20 0.42
▸ POLB P06746 1/20 0.39
▸ CCNK O75909 1/20 0.38
▸ CDK12 Q9NYV4 1/20 0.38
▸ KDM1A O60341 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ PCSK9 Q8NBP7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29312307 1.00 MAPK6 (0.44) MAPK6CYP11B1CYP11B2MAPTRAB9A
SCHEMBL15204865 0.90 CYP11B1 (0.49) CYP11B1CYP11B2MAPTRAB9AHCAR3
SCHEMBL15204867 0.90 CYP11B1 (0.49) CYP11B1CYP11B2MAPTRAB9AHCAR3
SCHEMBL15221643 0.90 CYP11B1 (0.49) CYP11B1CYP11B2MAPTRAB9AHCAR3
Hydrochloric Acid SCHEMBL15204797 0.89 CYP11B1 (0.48) CYP11B1CYP11B2MAPTRAB9AHCAR3
SCHEMBL15221612 0.89 RAB9A (0.47) CYP11B1CYP11B2MAPTRAB9AHCAR3
Hydrochloric Acid SCHEMBL15204688 0.87 RAB9A (0.46) CYP11B1CYP11B2MAPTRAB9AHCAR3
Hydrochloric Acid SCHEMBL15204377 0.87 RAB9A (0.46) CYP11B1CYP11B2MAPTRAB9AHCAR3
Hydrochloric Acid SCHEMBL15204689 0.87 RAB9A (0.46) CYP11B1CYP11B2MAPTRAB9AHCAR3
Hydrochloric Acid SCHEMBL15204378 0.87 RAB9A (0.46) CYP11B1CYP11B2MAPTRAB9AHCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023084449-A1 DIAMINOCYCLOPENTYLPYRIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER NOVARTIS AG (CH) 2023-05-19 — — WO disclosed
Send feedback